← Back to front page
United States · Wires & real time · PR Newswire

Yale School of Medicine Receives $10M Gift to Cure Type 1 Diabetes

Published by PR Newswire · United States 16 min ago
Credit: Anastasia Bukhman, courtesy Bukhman Foundation
Credit: Anastasia Bukhman, courtesy Bukhman Foundation · PR Newswire

Detailed summary

NEW HAVEN, Conn., Nov. 16, 2026 /PRNewswire/ -- Yale School of Medicine received a $10 million gift, funding a five-year, multi-investigator research program focused on reversing…

NEW HAVEN, Conn., Nov. 16, 2026 /PRNewswire/ -- Yale School of Medicine received a $10 million gift, funding a five-year, multi-investigator research program focused on reversing and ultimately curing type 1 diabetes.

The gift was given by Anastasia and Igor Bukhman, through the Bukhman Foundation.

"We are grateful to Anastasia and Igor Bukhman for their generosity and for the trust they have placed in our investigators," says Nancy J. Brown, MD, the Jean and David W. Wallace Dean of Yale School of Medicine. "This philanthropic support will enable these researchers to transform how type 1 diabetes is treated by developing precision therapies to modify its course and eventually prevent it."

For the Bukhman's, diabetes is personal, affecting their family members, including Anastasia's daughter, who was diagnosed at 3 years old. "It's a condition that has been in our family for a long time," she says, "and one that has played a big role in shaping the work we do today."

Kevan Herold, MD, the C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology), leads work focused on halting the immune attack on beta cells and developing personalized treatment approaches based on each patient's genetic and immunologic profile.

"The gift funds a number of projects which are all focused on stopping the immune-mediated pathogenesis of type 1 diabetes and restoring lost insulin-producing beta cells," says Herold. "The research is very goal-directed, and that goal is the prevention or reversal of disease. The studies will develop personalized approaches to treatment involving analyses of gene signatures, immunologic features, and beta cells from individuals with and at risk for diabetes."

In addition to Herold, the program will support the work of the following scientists:

Yale School of Medicine educates leaders in medicine and science, fostering curiosity and critical inquiry. It is a global leader in biomedical research, clinical care, and medical education.

Opening of the article, excerpted from PR Newswire. To read the rest, open the article on the publisher's site.

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading